The significance of previously failed biologics on the need for re-escalation at follow-up. The median number of previously failed biologics in patients that required re-escalation was 2 (1) versus 1 (1) in patients that did not (P < .001). The percent of patients requiring re-escalation grouped by the exact number of previously failed biologics is also shown.